comparemela.com

Latest Breaking News On - Andy hsieh - Page 2 : comparemela.com

Exelixis (EXEL) Q1 2024 Earnings Call Transcript

EXEL earnings call for the period ending March 31, 2024.

Joe catanzaro piper sandlerWilliam blairAndy hsiehGregory renzaAmy petersonJennifer chanLukas shumwayEtzer daroutLaura dillardDavid lebowitzChris shibutani goldman sachsSilvan tuerkcanChris sennerPeter lawsonChris shibutaniMorgan stanley

Is Viking Therapeutics Incredibly Undervalued?

The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.

Andy hsiehWilliam blairEli lillyGoldman sachsNovo nordiskViking therapeuticsImage sourceWall streetLeerink partnersViking therapeutic

Novo Nordisk: Why A Pullback Is Bullish For The Weight-Loss Drugs Kingpin

Novo Nordisk: Why A Pullback Is Bullish For The Weight-Loss Drugs Kingpin
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Eli lillyWilliam blairNovo nordiskAndy hsiehIndustry group rankingCardior pharmaceuticalsViking therapeuticsRelative strength rating

5 Things You Need to Know If You Buy Viking Therapeutics Stock Today

This high-flying biotech stock has captured investors' attention for all the right reasons.

Andy hsiehWilliam blairNovo nordisk ozempicDrug administrationViking therapeuticsNovo nordiskMadrigal pharmaceutical rezdiffra

Where Will Viking Therapeutics Stock Be in 10 Years?

Viking's future appears to be very promising, but market dynamics can change.

William blairEli lillyAndy hsiehNovo nordiskDrug administrationMadrigal pharmaceuticalsViking therapeutics

vimarsana © 2020. All Rights Reserved.